← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2001First marketed drug
Dec 30, 1987First NDA
Dec 30, 1987Last known activity
Nov 1, 2012
Acquired by Takeda on Jan 1, 2008
Timeline
1970s
- Jan 1, 1977
TAP Pharmaceuticals— Founded
2000s
- Aug 29, 2001
cefditoren— NDA Organization
- Jan 1, 2008
Takeda— Acquired By
Drugs by trial phase (9 distinct, 13 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Approved for
Marketed drugs (3)
Recent trials (14)
- NCT00928161CollaboratorN/ANov 1, 2012
- NCT00658736CollaboratorPhase 3Mar 1, 2008
- NCT00637416CollaboratorPhase 4Mar 1, 2008
- NCT01404832CollaboratorPhase 4Oct 1, 2007
- NCT00546117CollaboratorN/AOct 1, 2007
- NCT00335283CollaboratorPhase 3Aug 1, 2006
- NCT00274339CollaboratorN/ADec 1, 2005
- NCT00239551CollaboratorPhase 4Oct 1, 2005
- NCT00123110CollaboratorPhase 2Jul 1, 2005
- NCT00206375CollaboratorPhase 4May 1, 2003
- NCT00429494CollaboratorPhase 2Nov 1, 2002
- NCT00288691CollaboratorPhase 2Nov 1, 2001
- NCT00220350Lead sponsorPhase 2/Phase 3Oct 1, 2001
- NCT00220350CollaboratorPhase 2/Phase 3Oct 1, 2001
Details
- Founded
- Lake Forest, IL, US Jan 1, 1977
- First NDA
- Dec 30, 1987
- Last known activity
- Nov 1, 2012
Designations held
- Priority review
Notes
Acquired by Takeda